Bente Langdahl

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

Michael R. McClung, Andreas Grauer, Steven Boonen et al. · New England Journal of Medicine · 2014 · 1.2K citations

Medicine, Endocrinology, Bone Metabolism +12

Whole‐genome sequencing identifies EN1 as a determinant of bone density and fracture

Hou‐Feng Zheng, Vincenzo Forgetta, Yi‐Hsiang Hsu et al. · Nature · 2015 · 629 citations · Full text

Medicine, Genetics, Molecular Biology +13

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Bente Langdahl, Cesar Libanati, Daria B. Crittenden et al. · The Lancet · 2017 · 467 citations

Medicine, Endocrinology, Pharmacotherapy +14

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

Steven Boonen, Jean‐Yves Reginster, Jean‐Marc Kaufman et al. · New England Journal of Medicine · 2012 · 359 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +13

Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure

Marianne Rix, Helle Frost Andreassen, Peter Claes Eskildsen et al. · Kidney International · 1999 · 311 citations · Full text

Medicine, Nephrology, Bone Metabolism +16